Grantham, Mayo, Van Otterloo & Co (GMO)’s Cabot Corp CBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CBT
SCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CBT Position: Q4 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cabot Corp (CBT) in Q4 2022, closing a stake of 4,200 shares — an estimated $268K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CBT in Q2 2018 and held it in 14 quarters. The position peaked at $10.2M in Q1 2022. 314 funds tracked by Wall St. Rank hold CBT as of Q4 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cabot Corp position as of Q4 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,200 Cabot Corp shares in Q4 2022, an estimated $268K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cabot Corp in Q2 2018 and held it in 14 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Cabot Corp position peaked at $10.2M in Q1 2022.
- 314 funds tracked by Wall St. Rank held Cabot Corp as of Q4 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.